<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Rituximab is a chimeric mouse/human anti-CD20 antibody licensed for the treatment of low-grade non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and has recently also been shown to have a role in the treatment of diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We report a case of <z:e sem="disease" ids="C0038325" disease_type="Disease or Syndrome" abbrv="">Stevens-Johnson syndrome</z:e> after treatment with rituximab, which occurred in a 36-year-old man with relapsed follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The patient developed mucositis and <z:hpo ids='HP_0001945'>fevers</z:hpo> after the first two injections, followed by a florid maculopapular <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rash</z:e> with severe orogenital ulceration after the third infusion </plain></SENT>
<SENT sid="3" pm="."><plain>Over several weeks his symptoms progressed with severe cutaneous, orogenital and <z:e sem="disease" ids="C0151964" disease_type="Disease or Syndrome" abbrv="">conjunctival ulceration</z:e>, leading to visual problems and <z:hpo ids='HP_0004395'>malnutrition</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>No improvement occurred with steroids and <z:chebi fb="1" ids="35705">immunosuppressant</z:chebi> therapy </plain></SENT>
<SENT sid="5" pm="."><plain>A review of the literature reveals this to be the first reported case of <z:e sem="disease" ids="C0038325" disease_type="Disease or Syndrome" abbrv="">Stevens-Johnson syndrome</z:e> associated with rituximab therapy </plain></SENT>
</text></document>